Scarica l'app Stockscreener
5.37
0.37%
-0.02
Dopo l'orario di chiusura:
5.30
-0.07
-1.30%
Cytomx Therapeutics Inc Borsa (CTMX) Ultime notizie
CTMX: Barclays Raises Price Target from $6.00 to $8.00, Maintains Overweight Rating | CTMX Stock News - GuruFocus
Guggenheim Initiates Coverage of CytomX Therapeutics (CTMX) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on CytomX Therapeutics (CTMX) with 'Buy' Rating | CTMX Stock News - GuruFocus
CytomX Therapeutics (CTMX) Receives Target Price Upgrade from Pi - GuruFocus
CytomX Stock Rises 31% in a Month: Here's What You Should Know - Yahoo Finance
Risk Analysis: What is LILAKs book value per shareGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected - 富途资讯
CytomX Therapeutics' (NASDAQ:CTMX) investors will be pleased with their incredible 402% return over the last year - Yahoo Finance
CTMX Stock Price, Forecast & Analysis | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - Chartmill
Volatility Watch: Does CytomX Therapeutics Inc have strong EBITDA margins2025 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Is CytomX Therapeutics Inc stock heavily shortedEarnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
Drugmaker signed East Bay's biggest Q4 lease, moving away from South San Francisco - The Business Journals
Bull Run: Is CytomX Therapeutics Inc. stock a top pick in earnings seasonJobs Report & Reliable Price Breakout Alerts - Bộ Nội Vụ
Guidance Update: What hedge funds are buying CytomX Therapeutics Inc2025 AllTime Highs & Verified Technical Trade Signals - baoquankhu1.vn
Swing Trade: Will CytomX Therapeutics Inc stock recover faster than market2025 Buyback Activity & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Breakout Zone: Is CytomX Therapeutics Inc. stock gaining market shareJuly 2025 Action & Weekly Setup with ROI Potential - Улправда
Gainers Report: Will CytomX Therapeutics Inc stock recover faster than marketWeekly Volume Report & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
Is CytomX Therapeutics Inc. stock dividend yield sustainableJuly 2025 Decliners & Real-Time Volume Analysis Alerts - Улправда
Is CytomX Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Summary & Weekly Top Gainers Alerts - Улправда
CytomX Therapeutics, Inc. (CTMX) Stock Analysis: A 64.45% Potential Upside Amid Innovative Biotech Ventures - DirectorsTalk Interviews
Fed Meeting: Why CytomX Therapeutics Inc. stock could outperform in 2025Portfolio Profit Report & Intraday High Probability Alerts - Улправда
Why CytomX Therapeutics Inc. stock could outperform in 2025Weekly Earnings Recap & Momentum Based Trading Signals - Улправда
Is CytomX Therapeutics Inc. stock a safe investment in uncertain marketsWeekly Trading Summary & AI Powered Market Entry Strategies - ulpravda.ru
CytomX Therapeutics announces business update and company milestones for 2026 - marketscreener.com
Cytomx Therapeutics Announces Business Update And Company Milestones For 2026 - TradingView — Track All Markets
CytomX Therapeutics (CTMX) Reveals Plans for 2026 with Promising Clinical Developments - GuruFocus
CytomX Therapeutics Announces Business Update and Company Milestones for 2026 - The Manila Times
Piper Sandler and HC Wainwright stay bullish on CytomX (CTMX) - MSN
Why CytomX Therapeutics Inc. stock is recommended by analystsMarket Depth Overview & Low Entry Investment Growth - Улправда
Piper Sandler and H.C. Wainwright Stay Bullish on CytomX (CTMX) - Finviz
Is CytomX Therapeutics Inc a good long term investmentVolume Analysis Techniques & Free Trading Signals to Sharpen Your Edge - Early Times
What drives CytomX Therapeutics Inc 6C1 stock priceEmerging Market Stocks & High Return Stock Picks - earlytimes.in
What analysts say about CytomX Therapeutics Inc 6C1 stockEquity Performance Review & Collaborate and Win Together - earlytimes.in
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year HighHere's Why - MarketBeat
What drives CytomX Therapeutics Inc stock priceWeekly Market Snapshot & Investor Community Interactions - earlytimes.in
Chart Watch: Is CytomX Therapeutics Inc stock a safe investment in uncertain markets2025 Bull vs Bear & Verified Short-Term Trading Plans - moha.gov.vn
Will CytomX Therapeutics Inc. stock recover faster than peersChart Pattern Recognition & Exceptional Return Stocks - bollywoodhelpline.com
237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC - MarketBeat
Inspire Investing LLC Acquires Shares of 522,482 CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CytomX Therapeutics (STU:6C1) EV-to-OCF : -7.46 (As of Dec. 26, 2025) - GuruFocus
CytomX Therapeutics (NASDAQ:CTMX) Trading Up 5.4%Here's Why - MarketBeat
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX) - Seeking Alpha
CTMX (CytomX Therapeutics) EV-to-OCF : -7.47 (As of Dec. 22, 2025) - GuruFocus
CytomX Therapeutics, Inc.(NasdaqGS:CTMX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress - Insider Monkey
Can CytomX Therapeutics Inc. stock sustain free cash flow growthJuly 2025 News Drivers & Weekly High Return Opportunities - ulpravda.ru
Market Outlook: Why CytomX Therapeutics Inc stock could outperform in 2025Buy Signal & Free High Accuracy Swing Entry Alerts - moha.gov.vn
Sell Signal: Will CytomX Therapeutics Inc stock recover faster than peersJuly 2025 Summary & High Return Trade Guides - moha.gov.vn
How CytomX Therapeutics Inc. stock trades during market volatilityJuly 2025 Update & Fast Gain Swing Trade Alerts - Улправда
Is CytomX Therapeutics Inc. (6C1) stock undervalued by metricsJuly 2025 Sentiment & Community Trade Idea Sharing Platform - Улправда
Is CytomX Therapeutics Inc. stock gaining market share2025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда
CytomX Therapeutics' (NASDAQ:CTMX) earnings growth rate lags the 256% return delivered to shareholders - simplywall.st
Pullback Watch: What market sentiment indicators show for CytomX Therapeutics Inc. (6C1) stockMarket Performance Recap & Long-Term Safe Investment Plans - Улправда
2.85%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):